Chengsen Zhang is a Principal Scientist and Team Lead at Sutro Biopharma, Inc. since December 2022, specializing in mass spectrometry-based characterization for complex biologics and supporting IND-stage biologics programs. Previously at TrueBinding from July 2021 to December 2022, Chengsen led LC/MS-based analytical projects for large molecule therapeutic development and managed laboratory operations in a GxP-compliant setting. Prior experience includes working as a Senior Analytical Chemist at Firestone Building Products, overseeing laboratory operations and analytical testing, and serving as a Postdoctoral Research Associate at Indiana University, where Chengsen developed novel mass spectrometric assays. Educational qualifications include a Ph.D. in Analytical Chemistry from Peking University, an MBA from Indiana University - Kelley School of Business, and coursework as an Exchange Scholar at Purdue University in Mass Spectrometry.
This person is not in any teams
This person is not in any offices